GLP-1s Bringing Back Scurvy? Achondroplasia Drug Win; Intermittent Fasting Flop

(MedPage Today) — The meteoric rise of GLP-1 drugs for weight loss has raised concerns about potential malnutrition and even the comeback of scurvy. (The Hill)
An $80-per-month produce prescription subsidy failed to improve cardiometabolic health…